Effient Labeling Could Give Edge Against Plavix Through Pharmacogenetics

Lilly/Daiichi Sankyo's prasugrel has carefully constructed label to control risk of bleeding - but it also includes a pharmacogenetic argument that Effient works in clopidogrel non-responders.

More from Archive

More from Pink Sheet